HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIV
针对艾滋病毒感染者的健康相关干预措施
基本信息
- 批准号:2763645
- 负责人:
- 金额:$ 74.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS education /prevention HIV infections behavior modification behavioral /social science research tag clinical research coping handbook health behavior health care cost /financing heterosexuals homosexuals human subject human therapy evaluation interview intravenous drug abuse psychotherapy quality of life socioeconomics
项目摘要
The goal of this project is to design and test an intervention to reduce
sexual and injection practice risk behaviors among 1,200 HIV-infected
men and women in order to decrease the likelihood that persons with HIV
will transmit infection to others and to promote other health-related
behavior changes in PLH. The research will be focused on three HIV+
subgroups: women, men who have sex with men (MSM), and injection drug
users (IDUs). The study will be undertaken at four sites: Los Angeles,
New York, San Francisco, and Milwaukee. The project will begin with a
one-year period of formative Phase I studies conducted with 150 PLH (30
per site) using qualitative and life-history interviews to characterize
the physical, social, and interpersonal contexts that influence risk
behavior among PLH; understand stages of adaptation to serostatus; and
identify barriers to implementation of safer sex, positive health care
acts, and quality of life. The formative research phase will also allow
us to tailor the social action theoretical model guiding the
intervention to address issues affecting each subpopulation. Following
the formative research phase, a manual will be prepared for an
intervention of 15 individually-delivered sessions organized into three
modules with components that target health promotion, transmission risk
reduction, and psychological coping/relationship issues. In the Phase
2 main intervention trial, three subgroups of HIV-infected persons who
have recently engaged in high-risk behavior will be recruited in equal
numbers at each site yielding study-wide samples of HIV+ women (N=400),
MSM (N=400), and IDUs (N=400). Altogether, 1,200 PLHs project-wide will
be randomly assigned in equal numbers within each subgroup to an
immediate intervention condition or to a lagged intervention control
condition. Following two baseline interviews, participants will be
evaluated at 5-month intervals for the next 35 months. In addition to
anticipating changes in the primary (transmission risk acts) and
secondary (health care behaviors and quality of life) outcomes over time
and in response to each module, we will examine the impact of mediating
factors emerging from social action theory (coping skills, social
support, problem solving, HIV-related attitudes/beliefs, and
environmental context of risk acts), as well as participant background
factors (gender, ethnicity, history of transmission behaviors) on
primary and secondary outcomes. The study will be implemented by a
consortium of four sites in order to provide sufficient sample sizes to
assess the impact of the intervention; to enhance generalizability of
the findings; and to utilize the specialized expertise of each research
team. Cost-effectiveness analyses, and dissemination are planned as
part of this study.
本项目的目标是设计和测试一种干预措施,
1,200名艾滋病毒感染者的性行为和注射行为危险行为
男性和女性,以减少艾滋病毒感染者
将传染给他人,并促进其他与健康有关的
PLH的行为变化。 该研究将集中在三个艾滋病毒+
亚组:女性、男男性行为者(MSM)和注射毒品者
用户(IDUs)。 该研究将在四个地点进行:洛杉矶,
纽约,弗朗西斯科和密尔沃基。 该项目将开始一个
为期一年的形成性I期研究进行了150 PLH(30
使用定性和生活史访谈来描述
影响风险的物理、社会和人际环境
行为之间的PLH;了解阶段的适应血清状态;和
确定实施更安全性行为、积极的卫生保健
行为和生活质量。形成性研究阶段还将允许
我们要量身定制社会行动理论模型,
采取干预措施,解决影响每个亚群的问题。 以下
在初步研究阶段,将编写一本手册,
15个单独提供的会议分为三个
模块包含针对健康促进和传播风险的组件
减少和心理应对/关系问题。 期
2主要干预试验,三个亚组的艾滋病毒感染者谁
最近从事高风险行为将被招募在平等
每个研究中心产生研究范围内HIV阳性女性样本的数量(N=400),
MSM(N=400)和IDUs(N=400)。 项目范围内总共将有1,200个PLH
在每个分组内以相等的数量随机分配给一个
立即干预条件或滞后干预控制
条件 在两次基线访谈之后,参与者将
在接下来的35个月里,每隔5个月进行一次评估。 除了
预测主要(传输风险行为)的变化,
随着时间的推移,次要(医疗保健行为和生活质量)结果
针对每个模块,我们将研究调解的影响,
社会行动理论中出现的因素(应对技能,社会
支持,解决问题,与艾滋病毒有关的态度/信念,以及
风险行为的环境背景)以及参与者背景
因素(性别、种族、传播行为史)
主要和次要结果。 这项研究将由一个
为了提供足够的样本量,
评估干预措施的影响;提高
研究结果;并利用每项研究的专门知识
团队 计划进行成本效益分析和传播,
这项研究的一部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANKE A. EHRHARDT其他文献
ANKE A. EHRHARDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANKE A. EHRHARDT', 18)}}的其他基金
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIV
针对艾滋病毒感染者的健康相关干预措施
- 批准号:
6528834 - 财政年份:1998
- 资助金额:
$ 74.48万 - 项目类别:
Health Related Interventions For Persons Living With HIV
针对艾滋病毒感染者的健康相关干预措施
- 批准号:
6787192 - 财政年份:1998
- 资助金额:
$ 74.48万 - 项目类别:
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIV
针对艾滋病毒感染者的健康相关干预措施
- 批准号:
6392288 - 财政年份:1998
- 资助金额:
$ 74.48万 - 项目类别:
相似海外基金
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
- 批准号:
MR/V035304/1 - 财政年份:2022
- 资助金额:
$ 74.48万 - 项目类别:
Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
- 批准号:
10369859 - 财政年份:2021
- 资助金额:
$ 74.48万 - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10461964 - 财政年份:2021
- 资助金额:
$ 74.48万 - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10326617 - 财政年份:2021
- 资助金额:
$ 74.48万 - 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
- 批准号:
404211 - 财政年份:2018
- 资助金额:
$ 74.48万 - 项目类别:
Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
- 批准号:
9078083 - 财政年份:2015
- 资助金额:
$ 74.48万 - 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
- 批准号:
9079323 - 财政年份:2015
- 资助金额:
$ 74.48万 - 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
- 批准号:
9079336 - 财政年份:2015
- 资助金额:
$ 74.48万 - 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
- 批准号:
8472130 - 财政年份:2012
- 资助金额:
$ 74.48万 - 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
- 批准号:
8532661 - 财政年份:2011
- 资助金额:
$ 74.48万 - 项目类别:














{{item.name}}会员




